Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Feasibility of the extended, 48-h ambulatory blood pressure monitoring in hemodialysis patients: a multicenter study.

Journal of hypertension·2026
Same author

Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care.

Kidney international reports·2026
Same author

[Tempistica e Durata delle Visite Nefrologiche in Italia].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

"Interpreting Hemoadsorption in Septic Shock: Methodological Considerations and Dosing Implications".

Shock (Augusta, Ga.)·2026
Same author

Ketoanalogue-Supplemented Low-Protein Diet in Patients with Stage 4+ Chronic Kidney Disease in Italy: A Cost-Utility Analysis.

Nutrients·2026
Same author

The International, Prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: Interim Results in Patients with Septic Shock.

Annals of intensive care·2026

Related Experiment Video

Updated: Jun 8, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Hypertension in the elderly.

Antonio Del Giudice1, Giovanni Pompa, Filippo Aucella

  • 1IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy. a.delgiudice@operapadrepio.it

Journal of Nephrology
|September 28, 2010
PubMed
Summary

Hypertension affects 60-80% of elderly individuals, increasing cardiovascular risks. Effective therapies exist to reduce hypertension-related morbidity and mortality in older adults.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Hypertension prevalence is high in the elderly (60-80%) and projected to rise with population aging.
  • Hypertension is a significant cardiovascular risk factor, linked to stroke and mortality across all age groups.
  • Aging leads to arterial stiffness, increasing systolic blood pressure while diastolic pressure may remain stable or decrease in older adults.

Purpose of the Study:

  • To highlight the increasing prevalence and risks of hypertension in the elderly.
  • To discuss the specific hemodynamic changes associated with aging and hypertension.
  • To underscore the proven efficacy of hypertension treatment in reducing adverse cardiovascular outcomes in older populations.

Main Methods:

  • Review of epidemiological data on hypertension prevalence in the elderly.

Related Experiment Videos

Last Updated: Jun 8, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

  • Analysis of age-related physiological changes affecting blood pressure.
  • Synthesis of evidence from randomized clinical trials on hypertension treatment efficacy in older adults.
  • Main Results:

    • Systolic blood pressure increases with age due to arterial stiffness; diastolic pressure may remain unchanged or decrease.
    • Isolated systolic hypertension and high pulse pressure are common and significant risk factors in the elderly.
    • Numerous clinical trials confirm that hypertension therapy effectively reduces cardiovascular morbidity and mortality in older patients.

    Conclusions:

    • Hypertension poses a growing challenge in the aging population, with significant cardiovascular implications.
    • Understanding age-specific blood pressure changes is crucial for effective management.
    • Evidence strongly supports the benefits of antihypertensive therapy for reducing cardiovascular events and mortality in the elderly.